Abstract:Background: Schistosomiasis is a zoonotic parasitic disorder induced by the infestation of schistosomes, a genus of trematodes. MicroRNAs (miRNAs) in egg-derived exosomes are crucial for modulating the host's immune responses and orchestrating the pathophysiological mechanisms. Although the exosomes secreted by S. japonicum contain abundant miRNAs, the specific roles of these miRNAs in the pathogenesis of schistosomiasis-induced hepatic fibrosis are yet to be comprehensively elucidated. The egg exosomes of S. japonicum secrete miRNA-30, a novel miRNA. Methods: In vitro, the effect of miRNA-30 was evaluated by transfecting HSCs with miRNA mimics. The target gene biosignature for miRNA-30 was predicted using the miRDB software. The effect of miRNA-30 in hepatic fibrosis was evaluated by either elevating its expression in healthy mice or by inhibiting its activity in infected mice by administration of recombinant adeno-associated virus serotype eight vectors expressing miRNA-30 or miRNA sponges. Results: This novel miRNA can activate hepatic stellate cells (HSCs), the prinary effector cells of hepatic fibrosis, in vitro, i.e., it significantly increases the fibrogenic factors Col1(α1), Col3(α1), and α-SMA at both mRNA and protein levels. In addition, miRNA-30 may activate HSCs by targeting the host RORA gene. In addition, in vivo experiments were conducted by administering a recombinant adeno-associated viral vector to modulate the expression levels of miRNA-30. The overexpression of miRNA-30 in healthy mice significantly elevated the expression of Col1(α1), Col3(α1), and α-SMA at both the transcriptomic and proteomic scales. This overexpression was coupled with a pronounced augmentation in the hepatic hydroxyproline content. Conversely, the in vivo silencing of miRNA-30 in infected mice induced a considerable reduction in the size of hepatic granulomas and areas of collagen deposition. Hence, in vivo, modulation of miRNA-30 expression may play a pivotal role in ameliorating the severity of hepatic fibrosis in mice afflicted with S. japonica. Conclusions: The study results suggest that miRNA-30 may augment schistosomiasis-induced hepatic fibrosis through a probable interaction with the host RORA. Our study may improve the current theoretical framework regarding cross-species regulation by miRNAs of hepatic fibrosis in schistosomiasis.

MiR-130a-3p Alleviates Liver Fibrosis by Suppressing HSCs Activation and Skewing Macrophage to Ly6C<SUP>lo</SUP> Phenotype

MiR-130a-3p Alleviates Liver Fibrosis by Suppressing HSCs Activation and Skewing Macrophage to Ly6Clo Phenotype

MicroRNA-101 Suppresses Liver Fibrosis by Downregulating PI3K/Akt/mTOR Signaling Pathway

Mir-301A-3p Promotes Hepatic Stellate Cells Activation and Liver Fibrogenesis Via Regulating PTEN/PDGFR-β.

MicroRNA 200a inhibits liver fibrosis of schistosoma

MicroRNA-351 Promotes Schistosomiasis-Induced Hepatic Fibrosis by Targeting the Vitamin D Receptor

miRNA‐130b‐5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression

MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.

A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III

MicroRNA-29a-3p Prevents Schistosoma Japonicum -Induced Liver Fibrosis by Targeting Roundabout Homolog 1 in Hepatic Stellate Cells

miR-182-5p attenuates <italic>Schistosoma japonicum</italic>-induced hepatic fibrosis by targeting tristetraprolin

Retracted: MicroRNA‐29b‐3p Prevents Schistosoma Japonicum‐induced Liver Fibrosis by Targeting COL1A1 and COL3A1

Induction of hepatic fibrosis in mice with schistosomiasis by extracellular microRNA-30 derived from Schistosoma japonicum eggs

Human Umbilical Cord Mesenchymal Stem Cells Inhibit Liver Fibrosis Via the Microrna-148A-5p/slit3 Axis

A MicroRNA Derived from Schistosoma Japonicum Promotes Schistosomiasis Hepatic Fibrosis by Targeting Host Secreted Frizzled-Related Protein 1

MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7

MicroRNA-146b Regulates Hepatic Stellate Cell Activation Via Targeting of KLF4.

MicroRNA-130a and -130B Enhance Activation of Hepatic Stellate Cells by Suppressing PPARγ Expression: A Rat Fibrosis Model Study.

Upregulation of KSRP by Mir‐27b Attenuates Schistosomiasis‐induced Hepatic Fibrosis by Targeting TGF‐β1

Activation of Primary Hepatic Stellate Cells and Liver Fibrosis Induced by Targeting TGF-β1/Smad Signaling in Schistosomiasis in Mice

MiRNAs in liver fibrosis: new targets and opportunities for therapy